文献速递泌尿生殖腹部MR

前列腺癌诊断范式转变:活检前前列腺磁共振成像与靶向活检

Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy.
PubMed 文献 · Korean J Radiol · 2022-05-09

本文围绕前列腺癌惰性临床特征及选择性检出临床显著前列腺癌的需求,综述近期文献,说明活检前前列腺MRI联合靶向活检的诊断价值,并讨论该诊断范式转变中尚未解决的问题。

要点

  • 前列腺MRI已从分期工具拓展为活检前分诊工具,用于引导组织取样以提高临床显著前列腺癌检出率。
  • 国际合作为前列腺MRI提供了标准化的影像与报告系统。
  • 放射科医生需理解当前前列腺癌诊断范式的转变。

核心结论

  • 活检前前列腺MRI联合靶向活检具有诊断价值,前列腺MRI可作为活检前分诊工具以引导组织取样。
  • 该范式转变中仍存在尚未解决的问题。

研究设计与样本

  • 本文为综述,检索并汇总近期文献,讨论活检前前列腺MRI与靶向活检的诊断价值及范式转变中的未解决问题。

临床应用与阅片要点

  • 放射科医生需理解前列腺癌诊断的当前范式转变,以更好地进行前列腺癌诊断与管理。
  • 前列腺MRI已从用于已经传统系统活检确诊患者的 staging 工具,拓展为活检前引导组织取样的分诊工具。

局限性

  • 原文指出该范式转变中仍存在尚未解决的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

With regard to the indolent clinical characteristics of prostate cancer (PCa), the more selective detection of clinically significant PCa (CSC) has been emphasized in its diagnosis and management. Magnetic resonance imaging (MRI) has advanced technically, and recent international cooperation has provided a standardized imaging and reporting system for prostate MRI. Accordingly, prostate MRI has recently been investigated and utilized as a triage tool before biopsy to guide tissue sampling to increase the detection rate of CSC beyond the staging tool for patients in whom PCa was already confirmed on conventional systematic biopsy. Radiologists must understand the current paradigm shift for better PCa diagnosis and management. This article reviewed the recent literature, demonstrating the diagnostic value of pre-biopsy prostate MRI with targeted biopsy and discussed unsolved issues regarding the paradigm shift in the diagnosis of PCa.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Park, Kim. Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy. Korean J Radiol. 2022. PMID: 35555886. doi:10.3348/kjr.2022.0059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。